Literature DB >> 20177945

Venomics: a new paradigm for natural products-based drug discovery.

Irina Vetter1, Jasmine L Davis, Lachlan D Rash, Raveendra Anangi, Mehdi Mobli, Paul F Alewood, Richard J Lewis, Glenn F King.   

Abstract

The remarkable potency and pharmacological diversity of animal venoms has made them an increasingly valuable source of lead molecules for drug and insecticide discovery. Nevertheless, most of the chemical diversity encoded within these venoms remains uncharacterized, despite decades of research, in part because of the small quantities of venom available. However, recent advances in the miniaturization of bioassays and improvements in the sensitivity of mass spectrometry and NMR spectroscopy have allowed unprecedented access to the molecular diversity of animal venoms. Here, we discuss these technological developments in the context of establishing a high-throughput pipeline for venoms-based drug discovery.

Mesh:

Substances:

Year:  2010        PMID: 20177945     DOI: 10.1007/s00726-010-0516-4

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  61 in total

1.  Venom: the sharp end of pain therapeutics.

Authors:  Steven A Trim; Carol M Trim
Journal:  Br J Pain       Date:  2013-11

2.  Chemical punch packed in venoms makes centipedes excellent predators.

Authors:  Shilong Yang; Zhonghua Liu; Yao Xiao; Yuan Li; Mingqiang Rong; Songping Liang; Zhiye Zhang; Haining Yu; Glenn F King; Ren Lai
Journal:  Mol Cell Proteomics       Date:  2012-05-17       Impact factor: 5.911

3.  Optimized deep-targeted proteotranscriptomic profiling reveals unexplored Conus toxin diversity and novel cysteine frameworks.

Authors:  Vincent Lavergne; Ivon Harliwong; Alun Jones; David Miller; Ryan J Taft; Paul F Alewood
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

Review 4.  Privileged frameworks from snake venom.

Authors:  T A Reeks; B G Fry; P F Alewood
Journal:  Cell Mol Life Sci       Date:  2015-02-19       Impact factor: 9.261

Review 5.  Trends in peptide drug discovery.

Authors:  Markus Muttenthaler; Glenn F King; David J Adams; Paul F Alewood
Journal:  Nat Rev Drug Discov       Date:  2021-02-03       Impact factor: 84.694

6.  Sea anemone peptide with uncommon β-hairpin structure inhibits acid-sensing ion channel 3 (ASIC3) and reveals analgesic activity.

Authors:  Dmitry I Osmakov; Sergey A Kozlov; Yaroslav A Andreev; Sergey G Koshelev; Nadezhda P Sanamyan; Karen E Sanamyan; Igor A Dyachenko; Dmitry A Bondarenko; Arkadii N Murashev; Konstantin S Mineev; Alexander S Arseniev; Eugene V Grishin
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

7.  Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach.

Authors:  Julie K Klint; Jennifer J Smith; Irina Vetter; Darshani B Rupasinghe; Sing Yan Er; Sebastian Senff; Volker Herzig; Mehdi Mobli; Richard J Lewis; Frank Bosmans; Glenn F King
Journal:  Br J Pharmacol       Date:  2015-03-04       Impact factor: 8.739

8.  PEP-SiteFinder: a tool for the blind identification of peptide binding sites on protein surfaces.

Authors:  Adrien Saladin; Julien Rey; Pierre Thévenet; Martin Zacharias; Gautier Moroy; Pierre Tufféry
Journal:  Nucleic Acids Res       Date:  2014-05-06       Impact factor: 16.971

9.  Deep venomics reveals the mechanism for expanded peptide diversity in cone snail venom.

Authors:  Sébastien Dutertre; Ai-hua Jin; Quentin Kaas; Alun Jones; Paul F Alewood; Richard J Lewis
Journal:  Mol Cell Proteomics       Date:  2012-11-14       Impact factor: 5.911

10.  The insecticidal neurotoxin Aps III is an atypical knottin peptide that potently blocks insect voltage-gated sodium channels.

Authors:  Niraj S Bende; Eunji Kang; Volker Herzig; Frank Bosmans; Graham M Nicholson; Mehdi Mobli; Glenn F King
Journal:  Biochem Pharmacol       Date:  2013-03-06       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.